Eko is a digital health company applying machine learning in the fight against heart and lung disease with AI-powered smart stethoscopes. Its FDA-cleared technology is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect disease earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible.

Clinical leaders are able to easily customize workflows, then seamlessly disseminate protocols to frontline providers. Clinical Pathways are interactive decision trees with embedded links to clinical orders. AgileMD now has more than 4000 pathways live across emergency medicine, hospital medicine, surgery, oncology and primary care. 

At AgileMD, our mission is to improve patient outcomes by making evidence-based care universally accessible. We deliver this through intelligent clinical triggers, deeply integrated workflows, and actionable measurement that empowers clinicians at the point of care.

Founded at the University of Chicago more than 14 years ago, AgileMD solutions now support over 140,000 providers across 400+ U.S. hospitals, informing care for nearly 4.5 million patient encounters. Our impact has been validated in 90+ peer-reviewed publications, demonstrating meaningful improvements in care standardization, mortality, length of stay, and cost management.

AgileMD’s eCART all-cause early warning software is FDA-cleared and proven to outperform sepsis-specific scores. With embedded clinical pathways, it helps frontline teams identify risk earlier and follow role-specific guidelines to order, document, and escalate care. Additionally, our partners use clinical pathways across ambulatory and inpatient settings to improve care standardization across conditions.

AgileMD has been awarded nearly $3 million in federal funding from the U.S. Department of Health & Human Services (HHS), underscoring our commitment to advancing high-quality, data-driven clinical care.